Imaging in neuroblastoma: An update

Abstract

Neuroblastoma is the third common tumor in children. Imaging plays an important role in the diagnosis, staging, treatment planning, response evaluation and in follow-up of a case of Neuroblastoma. The International Neuroblastoma Risk Group task force has recently introduced an imaging-based staging system and laid down guidelines for uniform reporting of imaging studies. This review is an update on imaging in neuroblastoma, with emphasis on these guidelines.

Keywords

• image-defined risk factor
• international neuroblastoma risk group staging system
• metaiodobenzylguanidine
• neuroblastoma